1-5 of 5
Timothy P. Hughes
Close
Sort by
Journal Articles

Accelerated-phase CML: de novo and transformed

Naranie Shanmuganathan, Timothy P. Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2023) 2023 (1): 459–468.
https://doi.org/10.1182/hematology.2023000446
Published: 2023
Journal Articles

Management of TKI-resistant chronic phase CML

Timothy P. Hughes, Naranie Shanmuganathan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 129–137.
https://doi.org/10.1182/hematology.2022000328
Published: 2022
Journal Articles

Molecular monitoring in CML: how deep? How often? How should it influence therapy?

Naranie Shanmuganathan, Timothy P. Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 168–176.
https://doi.org/10.1182/asheducation-2018.1.168
Published: 2018
Journal Articles

Monitoring disease response to tyrosine kinase inhibitor therapy in CML

Timothy P. Hughes, Susan Branford
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 477–487.
https://doi.org/10.1182/asheducation-2009.1.477
Published: 2009
Journal Articles

Chronic Myeloid Leukemia

Junia V. Melo, Timothy P. Hughes, Jane F. Apperley
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 132–152.
https://doi.org/10.1182/asheducation-2003.1.132
Published: 2003